Association of PCSK9 Inhibitor Initiation on Statin Adherence and Discontinuation

Association of PCSK9 Inhibitor Initiation on Statin Adherence and Discontinuation

Background PCSK9is (proprotein convertase subtilisin/kexin type 9 inhibitors) are well tolerated, potently lower cholesterol, and decrease cardiovascular events when added to statins. However, statin adherence may decrease after PCSK9i initiation and alter clinical outcomes. We evaluate the associat...

Full description

Bibliographic Details
Main Authors: Christopher LaFratte, Samuel K. Peasah, Yan Huang, Deanne Hall, Urvashi Patel, Chester B. Good
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
adherence
discontinuation
low‐density lipoprotein
PCSK9
statin
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.123.029707

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.123.029707

Similar Items